Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
01/04/2026
Federal Reserve's Mursalem: Labor force shrinkage, population growth slowdown may restrict US economic growth.
Latest
2 m ago
NASA astronauts are about to embark on a journey around the moon, marking humanity's return to the vicinity of the moon for the first time in half a century.
4 m ago
US media: The US military has lost 16 MQ-9 "Reaper" drones.
4 m ago
Eli Lilly's oral weight loss drug in the United States has been approved, putting pressure on competitors Novo Nordisk. Eli Lilly's drug has been approved to help people lose weight or maintain previous weight loss results. The oral drug from Eli Lilly has been approved to help patients lose weight or maintain previous weight loss results. This review took less than four months thanks to a new project launched by the Food and Drug Administration (FDA) aiming to accelerate the market entry of drugs that meet national priorities, provide innovative therapies, or meet unmet medical needs. Eli Lilly is quickly catching up with Novo Nordisk, whose weight loss drug has been in high demand since its approval in December of last year. Eli Lilly has produced billions of doses of Foundayo to ensure quick market entry. Wall Street analysts predict that sales of this drug could reach $18 billion by 2030.
5 m ago
US storage chip stocks surged significantly.
6 m ago
Lei Lai Company's weight loss drug approved by the United States.
See all latest